SCHEMBL7929543

SCHEMBL7929543

CC1=CCCC(F)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6902342 0.72
SCHEMBL12806361 0.72
SCHEMBL12656516 0.70
SCHEMBL12806483 0.69 NPC1 (0.35)
SCHEMBL1685089 0.69
SCHEMBL13821140 0.69
SCHEMBL14616083 0.69
SCHEMBL14479840 0.69
SCHEMBL13473991 0.68
SCHEMBL12687509 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380881-B1 NOVEL BICYCLIC HETEROCYCLIC COMPOUND SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2017-01-25 EP disclosed
EP-2235014-B1 BICYCLIC DERIVATIVES OF AZABICYCLIC CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2013-10-09 EP disclosed
WO-2012134231-A2 BENZAMIDE DERIVATIVE AS CANNABINOID RECEPTOR (CB1) ANTAGONIST 한국화학연구원 (KR) 2012-10-04 WO disclosed
EP-1495018-B3 TRICYCLIC THROMBIN RECEPTOR ANTAGONISTS SCHERING CORP (US) 2011-03-16 EP disclosed
WO-2010038901-A1 7-PIPERIDINOALKYL-3,4-DIHYDROQUINOLONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-04-08 WO disclosed
US-7638546-B1 Imidazolyl derivatives IPSEN PHARMA S.A.S. (FR) 2009-12-29 US disclosed
WO-2008005368-A2 PIPERAZINES AS P2X7 ANTAGONISTS ABBOTT LABORATORIES (US) 2008-01-10 WO disclosed
US-20070032653-A1 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2007-02-08 US disclosed